● Recruiting

Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

Condition: Hepatocellular Carcinoma · Liver Cancer Stage IV · Pulmonary Metastases · Sponsor: Sun Yat-sen University

PhaseNA

Planned participants80

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This study intends to evaluate the efficacy and safety of cryoablation combined with Cardonilizumab and Bevacizumab in hepatocellular carcinoma with pulmonary metastases.

This description comes directly from the study's public registry record.

Talk to the study team

Qunfang Zhou, MD · 86 19868000115 · zhouqun988509@163.com

Always discuss trial participation with your own doctor first.

Locations (2)

Sun Yat-sen University Cancer Center	Guanzhou, Guangdong, China	Recruiting
Sun Yat-sen University Cancer Center	Guanzhou, Guangdong, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06265350